Evidence map›Paper›PMID 36485022›Full record

ArticleJMIR research protocols2022

A Text-Based Smoking Cessation Intervention for Sexual and Gender Minority Groups: Protocol for a Feasibility Trial.

Irene Tami-Maury, Rebecca Klaff, Allison Hussin, Nathan Grant Smith, Shine Chang, Lorna McNeill, Lorraine R Reitzel, Sanjay Shete, Lorien C Abroms

Registry-linked trialAbstract read
In one paragraph

Article in JMIR research protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05029362 (SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05029362 nacompletednot on this map

SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups

TypeinterventionalSponsorThe University of Texas Health Science Center, HoustonRan2022 to 2022Enrolled18ConditionsSmoking CessationArmsSmokefreeSGM
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Mobile Health Interventions for Substance Use Disorders.Annual review of clinical psychology · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Irene Tami-MaurySchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID https://orcid.org/0000-0002-1404-8641
Rebecca KlaffSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID https://orcid.org/0000-0001-5587-183X
Allison HussinSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID https://orcid.org/0000-0001-6637-5380
Nathan Grant SmithDepartment of Psychological, Health, and Learning Sciences, University of Houston, Houston, TX, United States.ORCID https://orcid.org/0000-0002-3142-686X
Shine ChangMD Anderson Cancer Center, The University of Texas, Houston, TX, United States.ORCID https://orcid.org/0000-0003-3804-9697
Lorna McNeillMD Anderson Cancer Center, The University of Texas, Houston, TX, United States.ORCID https://orcid.org/0000-0003-1594-6301
Lorraine R ReitzelMD Anderson Cancer Center, The University of Texas, Houston, TX, United States.ORCID https://orcid.org/0000-0002-7165-5720
Sanjay SheteMD Anderson Cancer Center, The University of Texas, Houston, TX, United States.ORCID https://orcid.org/0000-0001-7622-376X
Lorien C AbromsMilken Institute of Public Health, The George Washington University, Washington, DC, United States.ORCID https://orcid.org/0000-0001-6859-283X

Funding

Text2QuitPLUS: A Text-based Smoking Cessation Intervention for Sexual and Gender Minority GroupsK22CA237639 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI TAMI-MAURY, IRENE · 2020 to 2023
$527k
NCI NIH HHS K22 CA237639
6 · The paper itself

Abstract

backgroundSmoking among sexual and gender minority (SGM) groups, which include lesbian, gay, bisexual, transgender, and queer individuals, has been reported to be highly prevalent. This is attributed to several factors, including minority-specific stress and targeted tobacco marketing. Therefore, this population is at an increased risk for tobacco-related diseases. SMS text messaging programs have been found to be effective for smoking cessation and appeal to traditionally hard-to-reach populations over other interventions. It has also been suggested that targeted and tailored interventions could be more effective among SGM smokers because they can be designed to assure a safe, validating health care environment that enhances receptivity to cessation.

objectiveThe aim of this study is to develop SmokefreeSGM, a text-based smoking cessation program tailored to and tested among SGM smokers.

methodsThe study consists of three phases, culminating in a feasibility trial. In Phase 1, our research team will collaborate with a Community Advisory Board to develop and pretest the design of SmokefreeSGM. In Phase 2, the tailored text messaging program will be beta tested among 16 SGM smokers. Our research team will use a mixed-methods approach to collect and analyze data from participants who will inform the refinement of SmokefreeSGM. In Phase 3, a feasibility trial will be conducted among 80 SGM smokers either enrolled in SmokefreeSGM or SmokefreeTXT, the original text-based program developed by the National Cancer Institute for the general population. Our research team will examine recruitment, retention, and smoking abstinence rates at 1-, 3-, and 6-month follow-up. Additionally, a qualitative interview will be conducted among 32 participants to evaluate the feasibility and acceptability of the programs (SmokefreeSGM and SmokefreeTXT).

resultsThis study received approval from The University of Texas Health Science Center at Houston Committee for the Protection of Human Subjects to begin research on August 21, 2020. Recruitment for the beta testing of SmokefreeSGM (Phase 2) began in January 2022. We estimate that the feasibility trial (Phase 3) will begin in September 2022 and that results will be available in December 2023.

conclusionsFindings from this research effort will help reduce tobacco-related health disparities among SGM smokers by determining the feasibility and acceptability of SmokefreeSGM, an SGM-tailored smoking cessation intervention.

trial registrationClinicalTrials.gov NCT05029362; https://clinicaltrials.gov/ct2/show/NCT05029362. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/42553.

Indexed as

LGBTQ+mHealthmobile healthsexual and gender minoritiessmoking cessationSMS text messaging

Identifiers

PMID36485022
PMCPMC9789491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.